| Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship JR Molina, P Yang, SD Cassivi, SE Schild, AA Adjei Mayo clinic proceedings 83 (5), 584-594, 2008 | 4558 | 2008 |
| Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or … JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ... The lancet oncology 16 (2), 187-199, 2015 | 2031 | 2015 |
| Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology DS Ettinger, DE Wood, DL Aisner, W Akerley, J Bauman, LR Chirieac, ... Journal of the National Comprehensive Cancer Network 15 (4), 504-535, 2017 | 1198 | 2017 |
| NCCN guidelines insights: non–small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ... Journal of the National Comprehensive Cancer Network 19 (3), 254-266, 2021 | 819 | 2021 |
| Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ... Journal of the National Comprehensive Cancer Network 20 (5), 497-530, 2022 | 795 | 2022 |
| Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis SN Markovic, LA Erickson, RD Rao, RR McWilliams, LA Kottschade, ... Mayo Clinic Proceedings 82 (3), 364-380, 2007 | 776 | 2007 |
| Impact of intensity-modulated radiation therapy technique for locally advanced non–small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized … SG Chun, C Hu, H Choy, RU Komaki, RD Timmerman, SE Schild, ... Journal of Clinical Oncology 35 (1), 56, 2017 | 697 | 2017 |
| NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines DS Ettinger, DE Wood, C Aggarwal, DL Aisner, W Akerley, JR Bauman, ... Journal of the National Comprehensive Cancer Network 17 (12), 1464-1472, 2019 | 681 | 2019 |
| NCCN guidelines insights: non–small cell lung cancer, version 5.2018 DS Ettinger, DL Aisner, DE Wood, W Akerley, J Bauman, JY Chang, ... Journal of the National Comprehensive Cancer Network 16 (7), 807-821, 2018 | 509 | 2018 |
| Malignant peripheral nerve sheath tumor: analysis of treatment outcome WW Wong, T Hirose, BW Scheithauer, SE Schild, LL Gunderson International Journal of Radiation Oncology* Biology* Physics 42 (2), 351-360, 1998 | 503 | 1998 |
| NCCN guidelines insights: non–small cell lung cancer, version 4.2016 DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ... Journal of the National Comprehensive Cancer Network 14 (3), 255-264, 2016 | 461 | 2016 |
| Long-term results of NRG oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non–small-cell lung cancer JD Bradley, C Hu, RR Komaki, GA Masters, GR Blumenschein, SE Schild, ... Journal of Clinical Oncology 38 (7), 706, 2020 | 433 | 2020 |
| Treatment of small cell lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines JR Jett, SE Schild, KA Kesler, GP Kalemkerian Chest 143 (5), e400S-e419S, 2013 | 425 | 2013 |
| Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression D Rades, LJA Stalpers, T Veninga, R Schulte, PJ Hoskin, N Obralic, ... Journal of Clinical Oncology 23 (15), 3366-3375, 2005 | 414 | 2005 |
| Non–small cell lung cancer, version 6.2015 DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ... Journal of the National Comprehensive Cancer Network 13 (5), 515-524, 2015 | 403 | 2015 |
| Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non–small-cell lung cancer: neurocognitive and quality-of-life … A Sun, K Bae, EM Gore, B Movsas, SJ Wong, CA Meyers, JA Bonner, ... Journal of clinical oncology 29 (3), 279, 2011 | 384 | 2011 |
| A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG … GMM Videtic, C Hu, AK Singh, JY Chang, W Parker, KR Olivier, SE Schild, ... International Journal of Radiation Oncology* Biology* Physics 93 (4), 757-764, 2015 | 379* | 2015 |
| Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression D Rades, F Fehlauer, R Schulte, T Veninga, LJA Stalpers, H Basic, ... Journal of clinical oncology 24 (21), 3388-3393, 2006 | 371 | 2006 |
| Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non–small-cell lung cancer: primary analysis of radiation therapy … EM Gore, K Bae, SJ Wong, A Sun, JA Bonner, SE Schild, LE Gaspar, ... Journal of Clinical Oncology 29 (3), 272, 2011 | 367 | 2011 |
| The outcome of combined-modality therapy for stage III non–small-cell lung cancer in the elderly SE Schild, PJ Stella, SM Geyer, JA Bonner, WL McGinnis, JA Mailliard, ... Journal of clinical oncology 21 (17), 3201-3206, 2003 | 322 | 2003 |
Sujay VoraProfessor in Radiation Oncology在 mayo.edu 的电子邮件经过验证
